advertisement
Martin KR 9
Showing records 1 to 9 | Display all abstracts from Martin KR68994 Comparison of Latanoprostene Bunod 0.024% and Timolol Maleate 0.5% in Open-Angle Glaucoma or Ocular Hypertension: The LUNAR Study
Medeiros FA
American Journal of Ophthalmology 2016; 168: 250-259
68906 Distal retinal ganglion cell axon transport loss and activation of p38 MAPK stress pathway following VEGF-A antagonism
Foxton R
Cell Death and Disease 2016; 7: e2212
68994 Comparison of Latanoprostene Bunod 0.024% and Timolol Maleate 0.5% in Open-Angle Glaucoma or Ocular Hypertension: The LUNAR Study
Martin KR
American Journal of Ophthalmology 2016; 168: 250-259
68906 Distal retinal ganglion cell axon transport loss and activation of p38 MAPK stress pathway following VEGF-A antagonism
Osborne A; Martin KR
Cell Death and Disease 2016; 7: e2212
68994 Comparison of Latanoprostene Bunod 0.024% and Timolol Maleate 0.5% in Open-Angle Glaucoma or Ocular Hypertension: The LUNAR Study
Peace J
American Journal of Ophthalmology 2016; 168: 250-259
68906 Distal retinal ganglion cell axon transport loss and activation of p38 MAPK stress pathway following VEGF-A antagonism
Ng YS
Cell Death and Disease 2016; 7: e2212
68994 Comparison of Latanoprostene Bunod 0.024% and Timolol Maleate 0.5% in Open-Angle Glaucoma or Ocular Hypertension: The LUNAR Study
Scassellati Sforzolini B; Vittitow JL
American Journal of Ophthalmology 2016; 168: 250-259
68906 Distal retinal ganglion cell axon transport loss and activation of p38 MAPK stress pathway following VEGF-A antagonism
Shima DT
Cell Death and Disease 2016; 7: e2212
68994 Comparison of Latanoprostene Bunod 0.024% and Timolol Maleate 0.5% in Open-Angle Glaucoma or Ocular Hypertension: The LUNAR Study
Weinreb RN
American Journal of Ophthalmology 2016; 168: 250-259
